Document Detail

Proteomics as a novel HIV immune monitoring tool.
MedLine Citation:
PMID:  23380655     Owner:  NLM     Status:  In-Data-Review    
PURPOSE OF REVIEW: There is still a fundamental lack of understanding of what protected vaccinee's in the moderately successful RV144 Thailand trial. It is clear that better tools are needed to identify and study correlates of protection and immune responses to vaccine challenge. Quantitative mass spectrometry (MS) has evolved considerably to become a useful tool in biomarker discovery; however, until recently it has been scarcely used to define host responses to HIV exposure and/or viral infection. In this review we discuss current quantitative MS techniques, their application in current HIV studies as well as novel approaches that could be used to better examine innate or adaptive immune responses in HIV vaccine or microbicide trials.
RECENT FINDINGS: Several recently published studies have allowed researchers to utilize quantitative MS as part of a systems biology approach to better understand the HIV-affected host's interaction with HIV and/or vaccine challenge. Proteomics has shown it can play a major role in studies to demonstrate insight into HIV replication, early stages of pathogenesis, and identify potential correlates of mucosal protection.
SUMMARY: Novel advances in quantitative proteomic techniques are allowing the opportunity to profile and evaluate HIV specific innate and adaptive immune responses, and will increase our understanding of HIV pathogenesis.
Derek R Stein; Adam Burgener; Terry Blake Ball
Related Documents :
11365165 - Missouri requires actual exposure for recovery of damages.
8474215 - Prevalence and pattern of hiv infection in karachi.
24966525 - Evaluation of novel saquinavir analogs for resistance mutation compatibility and potent...
23865025 - Counseling and harm reduction centers for vulnerable women to hiv/aids in iran.
1973695 - Anal human papillomavirus infection among human immunodeficiency virus-seropositive and...
21992985 - Prevalence of herpes simplex virus type 2 infection, human immunodeficiency virus/herpe...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Current opinion in HIV and AIDS     Volume:  8     ISSN:  1746-6318     ISO Abbreviation:  Curr Opin HIV AIDS     Publication Date:  2013 Mar 
Date Detail:
Created Date:  2013-02-05     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101264945     Medline TA:  Curr Opin HIV AIDS     Country:  United States    
Other Details:
Languages:  eng     Pagination:  140-6     Citation Subset:  IM; X    
aUniversity of Manitoba, Department of Medical Microbiology bImmunology, Winnipeg cNational HIV and Retrovirology Laboratories, Public Health Agency of Canada, Winnipeg, Manitoba, Canada dUniversity of Nairobi, Department of Medical Microbiology, Nairobi, Kenya.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Gene array data relevant to immunological and virological monitoring of human immunodeficiency virus...
Next Document:  Study design issues in evaluating immune biomarkers.